Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review
The DOI matches its Crossref record.
Abstract
Background The effect and association of omega-3 fatty acids (n-3 FA) intake and biomarker levels with cardiovascular (CV) clinical and intermediate outcomes remains controversial. We update prior Evidence Reports of n-3 FA and clinical and intermediate CV disease (CVD) outcomes. Objectives Evaluate the effect of n-3 FA on clinical and selected intermediate CV outcomes and the association of n-3 FA intake and biomarkers with CV outcomes. The n-3 FA under review include eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), docosapentaenoic acid (DPA), stearidonic acid (SDA), and alphalinolenic acid (ALA). Data sources MEDLINE®, Embase®, the Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and CAB Abstracts from 2000 or 2002 to June 8, 2015, and eligible studies from the original reports and relevant existing systematic reviews. Review methods We included randomized controlled trials (RCTs) of any n-3 FA intake compared to no, lower, or other n-3 FA intake with an outcome of interest conducted in healthy adults, those at risk for CVD, or those with CVD. We also included prospective observational studies of the association between baseline n-3 FA intake or biomarker level and followup outcomes. We required 1 year or more of followup for clinical outcomes and 4 weeks for intermediate outcomes (blood pressure [BP] and lipids). Results From 11,440 citations (from electronic literature searches and existing systematic reviews), 829 abstract…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In studies of O3AEE in patients with HTG, 4 g/d (3.4 g/d EPA+DHA) has demonstrated greater efficacy (20%-30% reduction) than the 2-g/d dose (1.7 g/d EPA+DHA), which resulted in modest reductions of 11% to 15% 50,67 or no significant triglyceride reduction.36,68”
From Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association (2019) · cites this paper as [67]
Citations
Cited by
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., AlAbdulghafoor, F. K., Summerbell, C. D., Worthington, H. V., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub3 · Cited by 630
Rimm, E. B., Appel, L. J., Chiuve, S. E., Djoussé, L., Engler, M. B., Kris-Etherton, P. M., Mozaffarian, D., Siscovick, D. S., Lichtenstein, A. H., & On behalf of the American Heart Association Nutrition Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Epidemiology and Prevention; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology (2018) · Circulation · doi:10.1161/cir.0000000000000574 · Cited by 500
Self-citationSkulas-Ray, A. C., Wilson, P. W. F., Harris, W. S., Brinton, E. A., Kris-Etherton, P. M., Richter, C. K., Jacobson, T. A., Engler, M. B., Miller, M., Robinson, J. G., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000709 · Cited by 512
Nordic Nutrition Recommendations 2023
Blomhoff, R., Andersen, R., Arnesen, E. K., Christensen, J. J., Eneroth, H., Erkkola, M., Gudanaviciene, I., Halldórsson, Þ. I., Høyer-Lund, A., Lemming, E. W., et al. (2023) · Nordic Council of Ministers eBooks · doi:10.6027/nord2023-003 · Cited by 441
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., AlAbdulghafoor, F. K., Summerbell, C. D., Worthington, H. V., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub4 · Cited by 405
Metadata
- Authors
- Balk, E. M., Adam, G. P., Langberg, V., Halladay, C., Chung, M., Lin, L., Robertson, S., Yip, A., Steele, D., Smith, B. T., Lau, J., Lichtenstein, A. H., & Trikalinos, T. A.
- ORCID
- Published
- 2016-08
- Issue
- 223
- Pages
- 1-1252
- OpenAlex
- W2997536432
- Cited by
- 47
- References
- 0
- Citations by year
- 2024: 5 · 2023: 6 · 2022: 6 · 2021: 4 · 2020: 12 · 2019: 4 · 2018: 4 · 2017: 5 · 2016: 1
- Type
- report
- Language
- en
- Open access
- closed
- Locations
- PubMed (publishedVersion)
- Funders
- Agency for Healthcare Research and Quality (Contract No. 290-2012-00012-I)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Aquaculture Nutrition and Growth
- Keywords
- omega-3 fatty acids, cardiovascular disease, eicosapentaenoic acid, docosahexaenoic acid, docosapentaenoic acid, stearidonic acid, alpha-linolenic acid, marine oils, triglycerides, HDL cholesterol, LDL cholesterol, blood pressure, major adverse cardiovascular events, stroke, myocardial infarction, sudden cardiac death
- MeSH terms
- Cardiovascular Diseases, Docosahexaenoic Acids, Eating, Fatty Acids, Unsaturated, Humans, Myocardial Infarction, Eicosapentaenoic Acid, Biomarkers, Fatty Acids, Omega-3, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review. https://app.cochat.ai/papers/10.23970/ahrqepcerta223
- The paper
- Balk, E. M., Adam, G. P., Langberg, V., Halladay, C., Chung, M., Lin, L., Robertson, S., Yip, A., Steele, D., Smith, B. T., Lau, J., Lichtenstein, A. H., & Trikalinos, T. A. (2016). Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review. https://doi.org/10.23970/ahrqepcerta223
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.